BLFS

Insider Trades

Name	Value	Action	Price	Current Price
Casdin Partners Master Fund, L.P.10 Percent Owner $15M650k shares SellMay 21, 2026 $23.70 --
Casdin Partners Master Fund, L.P.10 Percent Owner $5.9M250k shares SellMay 20, 2026 $23.70 --
Casdin Partners Master Fund, L.P.10 Percent Owner $6.8M300k shares SellMay 19, 2026 $22.65 --
Foster Karen A.Chief Quality And Operations $49k2.6k shares SellMar 23, 2026 $19.17 --
Foster Karen A.Chief Quality And Operations $10k500 shares SellMar 9, 2026 $20.00 --
Foster Karen A.Chief Quality And Operations $2.0M96.9k shares SellMar 5, 2026 $20.15 --

News

gurufocus.comBioLife Solutions Inc (BLFS) Stock Up 3.1% and Still Undervalued -- GF Score: 73/100gurufocus.comMay 28

seekingalpha.comBioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 8

zacks.comBioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimateszacks.comMay 7

prnewswire.comBioLife Solutions Reports First Quarter 2026 Financial Resultsprnewswire.comMay 7

zacks.com4 Medical Product Stocks to Buy From a Challenging Industryzacks.comApr 27

Trade BLFS

About BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.

CEO: Roderick de Greef
IPO Date: Nov 22, 1989

Market Data

Open: $25.85
High: $26.83
Low: $25.65
Volume: 1.1M
Avg Volume: 621.3K
52W High: $29.62
52W Low: $17.86

Valuation

Market Cap: $1.3B
Enterprise Value: $1.3B
Dividend Yield: 0.00%

Financials

Free Cash Flow: $11M
Revenue: $96M
Net Income: $-12M
Cash: $33M
Debt: $18M

Events

EarningsAug 6

EPS est. 0.025